Last updated on January 2019

Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Colorectal Cancer
  • Age: Between 40 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Adults population over 40 years of age
  • Patients who understood this study process and agreed to participation of this study
  • Colon cancer patients who have been confirmed as colorectal cancer by endoscopic biopsy within 1 month
  • Colon cancer patients who received no anticancer treatment such as surgery, chemotherapy, radiation therapy after cancer diagnosis.
  • Colorectal adenoma and normal control group: Patients undergoing colonoscopy for diagnostic purposes or colorectal cancer screening.

Exclusion Criteria:

  • Patients who did not agree to participate in the study and did not write their informed consent
  • Vulnerable subjects with mental retardation or severe psychiatric illness.
  • Patients who are not appropriate enrollment of this study by researchers judgement.
  • Patients who have had an immunosuppressive drug within 6 months.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.